Publications by authors named "Eytan M Stein"

58Publications

BCR-ABL tyrosine kinase inhibitor (TKI)-induced nephropathy: An under-recognized phenomenon.

Leuk Res Rep 2020 8;14:100211. Epub 2020 Jun 8.

Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lrr.2020.100211DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327424PMC
June 2020

Response Kinetics and Clinical Benefits of Nonintensive AML Therapies in the Absence of Morphologic Response.

Clin Lymphoma Myeloma Leuk 2020 02 26;20(2):e66-e75. Epub 2019 Nov 26.

Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre, Toronto, Canada; Leukemia Program, Department of Medical Oncology and Hematology, University Health Network, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2019.11.017DOI Listing
February 2020

Immunotherapy for acute myeloid leukemia: from allogeneic stem cell transplant to novel therapeutics.

Leuk Lymphoma 2019 12 23;60(14):3350-3362. Epub 2019 Jul 23.

Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1639167DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928392PMC
December 2019

Molecular and cytogenetic characteristics of myeloid malignancies following luminal gastrointestinal cancer.

Leuk Res 2019 07 24;82:19-23. Epub 2019 May 24.

Department of Medicine, Memorial Sloan Kettering Cancer Center, USA; Division of Hematologic Malignancies, Leukemia Service, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY, 10065, USA; Department of Medicine, Weill Cornell Medical College, 1300 York Ave, New York, NY, 10065, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2019.05.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7051794PMC
July 2019

How Precision Medicine Is Changing Acute Myeloid Leukemia Therapy.

Am Soc Clin Oncol Educ Book 2019 Jan 17;39:411-420. Epub 2019 May 17.

2 Northwestern University, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_238687DOI Listing
January 2019

Intraocular B-cell Acute Lymphoblastic Leukemia.

Ophthalmol Retina 2018 08 2;2(8):826. Epub 2018 Aug 2.

Department of Ophthalmology, Weill Cornell Medical Center, Ithaca, New York; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oret.2018.03.002DOI Listing
August 2018

SOHO State of the Art Update and Next Questions: IDH Therapeutic Targeting in AML.

Clin Lymphoma Myeloma Leuk 2018 12 21;18(12):769-772. Epub 2018 Oct 21.

Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S21522650183142
Publisher Site
http://dx.doi.org/10.1016/j.clml.2018.10.007DOI Listing
December 2018

Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML.

N Engl J Med 2018 Jun 2;378(25):2386-2398. Epub 2018 Jun 2.

From the University of Texas M.D. Anderson Cancer Center, Houston (C.D.D., H.M.K.); Memorial Sloan Kettering Cancer Center (E.M.S., M.S.T.) and Weill Cornell Medical College (G.J.R.), New York; Institut Gustave Roussy, Villejuif (S.B., C.W.), and Centre Hospitalier Universitaire Bordeaux, Bordeaux (A.P.) - both in France; Northwestern University, Chicago (J.K.A.); Ohio State University Wexner Medical Center, Columbus (A.S.M.); Sylvester Comprehensive Cancer Center, University of Miami, Miami (R.S.); University of Texas Southwestern Medical Center, Dallas (R.H.C.); University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco (G.N.M.), and City of Hope Medical Center, Duarte (A.S.S.) - both in California; University of Colorado School of Medicine, Aurora (D.A.P.); Sarah Cannon Research Institute, Nashville (W.D.); Massachusetts General Hospital Cancer Center (A.T.F.) and Dana-Farber Cancer Institute (R.M.S.), Boston, and Agios Pharmaceuticals, Cambridge (S.C., H.W., V.Z., K.E.Y., S.M.K., H.Y., D.D., B.F., M.G., H.L., S.A., B.W., E.C.A.) - all in Massachusetts; University of Alabama at Birmingham, Birmingham (H.P.E.); Johns Hopkins University, Baltimore (G.T.P.); Washington University School of Medicine, St. Louis (G.L.U.); Mayo Clinic, Jacksonville, FL (J.M.F.); Oregon Health and Science University Knight Cancer Institute, Portland (E.T.); Hollings Cancer Center, Medical University of South Carolina, Charleston (R.K.S.); Winship Cancer Institute of Emory University, Atlanta (M.L.A.); Mayo Clinic, Phoenix, AZ (J.L.S.); and Cleveland Clinic, Cleveland (M.A.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1716984DOI Listing
June 2018

FLT3 inhibitors for relapsed or refractory acute myeloid leukaemia.

Authors:
Eytan M Stein

Lancet Oncol 2018 07 31;19(7):849-850. Epub 2018 May 31.

Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(18)30335-8DOI Listing
July 2018

Time to repeal and replace response criteria for acute myeloid leukemia?

Blood Rev 2018 09 27;32(5):416-425. Epub 2018 Mar 27.

The Alfred Hospital and Monash University, Melbourne, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.blre.2018.03.006DOI Listing
September 2018

Widespread use of measurable residual disease in acute myeloid leukemia practice.

Leuk Res 2018 04 13;67:92-98. Epub 2018 Feb 13.

Department of Medicine, Memorial Sloan Kettering Cancer Center, USA; Division of Hematologic Oncology, Leukemia Service, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY, 10065, USA; Department of Medicine, Weill Cornell Medical College, 1300 York Ave, New York, NY, 10065, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2018.02.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029617PMC
April 2018

Enasidenib, a targeted inhibitor of mutant IDH2 proteins for treatment of relapsed or refractory acute myeloid leukemia.

Authors:
Eytan M Stein

Future Oncol 2018 Jan 18;14(1):23-40. Epub 2017 Sep 18.

Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Ave, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2017-0392DOI Listing
January 2018

Minimal Residual Disease in Acute Myeloid Leukemia: Prognostication and Pitfalls.

Authors:
Eytan M Stein

J Oncol Pract 2017 08;13(8):485-486

Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2017.025338DOI Listing
August 2017

Telomere length and associations with somatic mutations and clinical outcomes in acute myeloid leukemia.

Leuk Res 2016 10 25;49:62-5. Epub 2016 Jul 25.

Leukemia Service, Department of Medicine, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2016.07.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526052PMC
October 2016

Acute myeloid leukemia masquerading as hepatocellular carcinoma.

J Gastrointest Oncol 2016 Jun;7(3):E31-5

1 Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA ; 2 Department of Medicine, Weill Cornell Medical College, New York, NY, USA ; 3 Departments of Pathology and Laboratory Medicine, 4 Department of Radiology, 5 Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA ; 6 Department of Surgery, Weill Cornell Medical College, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/jgo.2015.12.01DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4880775PMC
June 2016

Evolving Therapies in Acute Myeloid Leukemia: Progress at Last?

Am Soc Clin Oncol Educ Book 2016 ;35:e302-12

From the Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY; The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_161258DOI Listing
January 2017

Emerging therapeutic drugs for AML.

Blood 2016 Jan 10;127(1):71-8. Epub 2015 Dec 10.

Leukemia Service, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2015-07-604538DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4915807PMC
January 2016

Molecularly targeted therapies for acute myeloid leukemia.

Authors:
Eytan M Stein

Hematology Am Soc Hematol Educ Program 2015 ;2015:579-83

Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://www.asheducationbook.org/cgi/doi/10.1182/asheducation
Publisher Site
http://dx.doi.org/10.1182/asheducation-2015.1.579DOI Listing
October 2016

IDH2 inhibition in AML: Finally progress?

Authors:
Eytan M Stein

Best Pract Res Clin Haematol 2015 Jun-Sep;28(2-3):112-5. Epub 2015 Oct 19.

Leukemia Service, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, 1275 York Avenue, New York, NY 10065, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2015.10.016DOI Listing
September 2016

Molecular Pathways: IDH2 Mutations-Co-opting Cellular Metabolism for Malignant Transformation.

Authors:
Eytan M Stein

Clin Cancer Res 2016 Jan 9;22(1):16-9. Epub 2015 Nov 9.

Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5050039PMC
http://dx.doi.org/10.1158/1078-0432.CCR-15-0362DOI Listing
January 2016

Secondary acute lymphoblastic leukaemia is constitutional and probably not related to prior therapy.

Br J Haematol 2015 Jul 30;170(1):50-5. Epub 2015 Mar 30.

Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13386DOI Listing
July 2015

Mixed lineage rearranged leukaemia: pathogenesis and targeting DOT1L.

Curr Opin Hematol 2015 Mar;22(2):92-6

Leukemia Service, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOH.0000000000000123DOI Listing
March 2015

Acute promyelocytic leukemia in children and adolescents.

Acta Haematol 2014 10;132(3-4):307-12. Epub 2014 Sep 10.

Leukemia Service, Memorial Sloan-Kettering Cancer Center, New York, N.Y., USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000365117DOI Listing
November 2014

Searching the central nervous system for relapsed acute promyelocytic leukemia.

Leuk Lymphoma 2013 Dec;54(12):2584-5

Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center , New York, NY , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2013.803548DOI Listing
December 2013

Persistent problems with persistent disease: minimal residual disease in acute myelogenous leukemia.

Biol Blood Marrow Transplant 2013 Feb;19(2):170-1

Leukemia Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, New York, New York 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2012.12.009DOI Listing
February 2013

Provocative pearls in diagnosing and treating acute promyelocytic leukemia.

Oncology (Williston Park) 2012 Jul;26(7):636-41

Memorial Sloan-Kettering Cancer Center, New York, New York 100065, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4075426PMC
July 2012

Remission induction in acute myeloid leukemia.

Int J Hematol 2012 Aug 13;96(2):164-70. Epub 2012 Jul 13.

Memorial Sloan Kettering Cancer Center, Leukemia Service, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-012-1121-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4052975PMC
August 2012

Does arsenic trioxide impact fertility?

Leuk Lymphoma 2012 Nov 21;53(11):2099-100. Epub 2012 May 21.

Weill Cornell Medical College, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2012.685737DOI Listing
November 2012

Hepatitis C and non-Hodgkin lymphoma: the clinical perspective.

Hepatology 2012 Feb;55(2):634-41

Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.25499DOI Listing
February 2012